Multiple Endocrine and Neoplastic Diseases After Unsuccessful Treatment of Hepatitis C With Interferon and Ribavirin

Am J Med Sci. 2017 Jul;354(1):66. doi: 10.1016/j.amjms.2016.10.001. Epub 2016 Oct 18.

Authors

Shirin Attarian¹, Janaki Sharma², Andreas Kaubisch², Joel Zonszein³, Missak Haigentz Jr²

Affiliations

¹ Division of Oncology, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, New York. Electronic address: sattaria@montefiore.org.
² Division of Oncology, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, New York.
³ Division of Endocrinology, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, New York.

PMID: 28755736
DOI: 10.1016/j.amjms.2016.10.001

No abstract available

Publication types

Case Reports

MeSH terms

Carcinoma, Hepatocellular* / chemically induced
Carcinoma, Hepatocellular* / diagnostic imaging
Diabetes Mellitus, Type 1* / chemically induced
Diabetes Mellitus, Type 1* / diagnostic imaging
Humans
Interferon alpha-2
Interferon-alpha* / administration & dosage
Interferon-alpha* / adverse effects
Liver Neoplasms* / chemically induced
Liver Neoplasms* / diagnostic imaging
Male
Middle Aged
Polyendocrinopathies, Autoimmune* / chemically induced
Polyendocrinopathies, Autoimmune* / diagnostic imaging
Polyethylene Glycols* / administration & dosage
Polyethylene Glycols* / adverse effects
Recombinant Proteins / administration & dosage
Recombinant Proteins / adverse effects
Ribavirin* / administration & dosage
Ribavirin* / adverse effects
Thyroid Diseases / chemically induced
Thyroid Diseases / diagnostic imaging

Substances

Interferon alpha-2
Interferon-alpha
Recombinant Proteins
Polyethylene Glycols
Ribavirin
peginterferon alfa-2b